180 Life Sciences: ATNF CEO, Jim Woody, says that the company is focused on drug development that fulfills unmet needs in inflammatory diseases. It seeks to develop novel drugs addressing separate areas of inflammation. What is next for 180 Life Sciences and how will the stock price be affected?
The Watch List
03 May 2021
SHARE
The Watch List
22 Feb 2022
The Watch List
20 Apr 2022
The Watch List
28 Apr 2022
Market On Close
05 Apr 2022
The Watch List
01 Mar 2022
Trading 360
18 Apr 2022